ChemoCentryx (NASDAQ:CCXI) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
ChemoCentryx missed estimated earnings by 16.0%, reporting an EPS of $-0.58 versus an estimate of $-0.5.
Revenue was up $2.04 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.13 which was followed by a 0.08% drop in the share price the next day.
Here's a look at ChemoCentryx's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.45 | -0.54 | -0.40 | -0.33 |
| EPS Actual | -0.32 | -0.56 | -0.43 | -0.43 |
| Revenue Estimate | 13.48M | 4.85M | 7.93M | 7.99M |
| Revenue Actual | 17.74M | 1.81M | 10.35M | 4.36M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
